Tenstorrent’s $1.5 billion Series E topped the week’s biggest funding rounds, and AI companies took the first two spots, according to Crunchbase News. The Santa Clara developer of AI processors and systems raised the money at a $6.2 billion valuation, with Trace Capital and Innovation X leading. Flapping Airplanes followed with a $1 billion Series A.
Seven of the ten rounds are confirmed in the reporting behind this story, and together they add up to $3.727 billion. The list runs from AI chips and foundation-model labs to GPS, drug discovery and a $200 million financing for Warhound, a startup that wants to breed elite military dogs. We looked at that last deal on its own in our report on Warhound’s $200 million raise.
Below, we break down each confirmed round, check the valuation math, place the week against other 2026 AI financings, and lay out what we expect next. Where the sources do not confirm a detail, we say so instead of filling the gap.
Don't miss new tech stories on Google
Add Tech Insider once in the Google app and our stories appear in your news suggestions.
The Week’s Biggest Funding Rounds at a Glance
Crunchbase News described the week as another busy stretch for AI-related startup funding, with large rounds and some quirky companies mixed in. The two largest financings went to Tenstorrent and Flapping Airplanes. The quirkiest, in the outlet’s words, was the Warhound deal. Rounds in biotech, space tech and physical AI filled out the rest of the list.
The table below shows the seven rounds we can confirm, sorted by size. Details that the available reporting does not state appear as “Not confirmed” rather than guesses.
| Company | Round | Amount | Lead investor(s) | Valuation | Base and focus |
|---|---|---|---|---|---|
| Tenstorrent | Series E | $1.5B | Trace Capital, Innovation X | $6.2B | Santa Clara, AI processors and systems |
| Flapping Airplanes | Series A | $1B | Lux Capital, Index Ventures | About $6B (TechCrunch headline) | San Francisco, AI lab focused on cheaper models |
| ASI | Series C | $325M | Spark Capital | $3B | Boston, AI for critical infrastructure |
| Xona | Series D | $250M | Future Ventures | $2.4B | Burlingame, next-generation GPS |
| Pathos AI | Series E | $237M | Bristol-Myers Squibb | About $3B post-money | New York, AI drug development |
| Warp Sciences | Series A | $215M | Lightspeed Venture Partners | Not confirmed | AI and robotics for medicine development |
| Warhound | Financing | $200M | Not confirmed | Not confirmed | Breeding elite military dogs |
Tenstorrent’s $1.5B Series E Sets the Pace
Tenstorrent sits at the top of the list for a simple reason. It sells the hardware layer that AI workloads run on, and investors keep writing very large checks for that layer. Crunchbase News describes the company as a developer of AI processors and systems. The $1.5 billion Series E, led by Trace Capital and Innovation X, set a valuation of $6.2 billion.
The round is the largest of the seven by a wide margin. It alone accounts for about 40% of the $3.727 billion total across the confirmed deals. That concentration matters for how you read the week. Strip out Tenstorrent and the remaining six rounds still total $2.227 billion, but the headline number shrinks by more than a third.
The company competes in a market where the incumbent supplier controls most of the conversation. Our recent coverage of AI model and infrastructure news shows how much of the industry’s attention sits on one chip vendor. A $1.5 billion Series E gives Tenstorrent room to fund silicon development and system builds without leaning on a public listing. The reporting we have does not detail how the company plans to spend the money, so we will not guess at product roadmaps.
Flapping Airplanes Raises $1B Less Than 10 Months After Its Seed
Flapping Airplanes closed a $1 billion Series A led by Lux Capital and Index Ventures, per Crunchbase News. The San Francisco company calls itself an AI lab, and it focuses on building models that cost less to train and run. The round arrived less than 10 months after it raised a $180 million seed financing.
Do the arithmetic and the jump is stark. Going from $180 million to $1 billion in under 10 months means the company raised about 5.6 times as much in its second institutional round as in its first. TechCrunch’s headline on the deal put the valuation at $6 billion, which would make Flapping Airplanes roughly the same price as Tenstorrent on paper despite having raised its seed round less than 10 months earlier.
Why investors back a cheaper-model thesis
Training and serving frontier models costs a great deal. A lab that can cut either bill attracts attention from investors who worry about the economics of today’s largest systems. Asher Spector, the company’s founder, framed the pitch around data efficiency, and we quote him in the expert section below. The sources we have do not publish benchmark results for Flapping Airplanes models, so the claim remains a thesis, not a proven result.
ASI Lands $325M to Secure Critical Infrastructure
Boston-based ASI develops AI technology for securing and operating critical infrastructure, including aviation, transportation and defense. Its $325 million Series C was led by Spark Capital and set a $3 billion valuation, Crunchbase News reports.
This is the least flashy deal among the top four, and it may be the most telling. Infrastructure operators buy slowly, demand reliability and sign long contracts. Investors paying a $3 billion price for that customer base signal confidence that AI has moved from pilot projects into systems where failure carries real costs. A Series C of this size also suggests the company has revenue or contracts that justify the multiple, although the available reporting does not state either figure.
Xona’s $250M Series D Targets a Next-Generation GPS
Xona is building a next-generation version of GPS, according to Crunchbase News. Future Ventures led the $250 million Series D, which valued the Burlingame, California company at $2.4 billion.
Xona does not fit the AI label as neatly as its neighbors on the list. Positioning and timing sit underneath almost every modern network, from logistics fleets to financial systems, so a company that wants to improve on GPS touches a wide slice of the economy. Crunchbase’s roundup lists it alongside the AI deals. We have no confirmed details on the satellite count, launch schedule or customers, so we leave those out.
Pathos AI and Warp Sciences Put $452M Into AI Drug Discovery
Two of the seven rounds target medicine. Pathos AI, based in New York, applies AI to drug development and completed a $237 million Series E at a post-money valuation around $3 billion. Bristol-Myers Squibb led the financing. Warp Sciences uses AI and robotics to help develop new medicines faster and raised a $215 million Series A led by Lightspeed Venture Partners. Together the two rounds total $452 million.
One detail stands out. A large pharmaceutical company, not a venture firm, led the Pathos round. That tells you how drugmakers now treat AI discovery platforms, as assets worth owning a stake in instead of vendors to rent. It echoes a move we covered recently, when OpenAI bought Orchestra Bio, a four-year-old startup working on drug discovery.
Warp Sciences adds a robotics angle. Pairing models with lab automation aims to shorten the loop between a hypothesis and a test result. The sources do not state Warp’s valuation, and trackers disagree, so we list it as not confirmed in the table above.
Warhound’s $200M Financing Is the Week’s Oddest Entry
Crunchbase News called Warhound the quirkiest round of the week. The startup is seeking to breed elite military dogs, and it raised $200 million to do it. The sources available for this article do not confirm the round stage, the lead investor or the valuation, so we avoid labeling it beyond a financing.
Defense-adjacent startups have been landing big checks, and this deal fits that run. It is also a reminder that a “biggest rounds” list rewards unusual stories as well as technical ones. Warhound’s $200 million equals about 5.4% of the confirmed seven-round total, which is small next to Tenstorrent but large for a business that, on the face of it, involves animal breeding.
What the Last Three Entries Leave Unanswered
Crunchbase’s weekly list covers ten financings. The reporting we could verify for this article names seven. The remaining three entries lack confirmed company names, amounts and investors in our fact base, so we do not name them or estimate their size.
This matters for any total you read. The $3.727 billion figure here is a floor, not the week’s full tally. Readers who want the complete list should check the original Crunchbase News roundup. We would rather publish a smaller verified number than a bigger one with invented pieces.
Market Impact: Where the $3.7B Landed
Grouping the seven confirmed rounds by theme shows where the money went. AI compute and model labs took the biggest slice. Infrastructure, navigation and defense came next. Life sciences followed. The sector labels are our grouping, not Crunchbase’s, and the amounts come straight from the announced round sizes.
| Theme | Companies | Combined amount | Share of $3.727B |
|---|---|---|---|
| AI compute and model labs | Tenstorrent, Flapping Airplanes | $2.5B | 67.1% |
| Infrastructure, navigation, defense | ASI, Xona, Warhound | $775M | 20.8% |
| AI-driven life sciences | Pathos AI, Warp Sciences | $452M | 12.1% |
| Total, seven confirmed rounds | 7 companies | $3.727B | 100% |
Two companies absorbed two-thirds of the confirmed money. That concentration is the main market signal. Capital is flowing to a small number of very large bets, while a long tail of smaller rounds shares what remains. For founders outside the top tier, the week’s list offers a mixed message. Investors have plenty of money for AI, but they are writing fewer, bigger checks.
Valuation Math: Raise Size Versus Price Tag
Comparing the size of each round with the valuation it set reveals how much of each company investors bought. The ratio is rough, since the sources do not always say whether a figure is pre- or post-money, but it still separates the aggressive raises from the cautious ones.
| Company | Raise | Valuation | Raise as share of valuation |
|---|---|---|---|
| Tenstorrent | $1.5B | $6.2B | About 24% |
| Flapping Airplanes | $1B | About $6B | About 17% |
| ASI | $325M | $3B | About 11% |
| Xona | $250M | $2.4B | About 10% |
| Pathos AI | $237M | About $3B | About 8% |
Tenstorrent’s round equals roughly a quarter of its valuation, which is a heavy raise relative to the price. That usually points to a capital-intensive business. Chip design and system builds eat cash before they earn it. At the other end, Pathos AI raised about 8% of its valuation, a more typical pace for a company with a drug pipeline to fund over several years. Warp Sciences and Warhound do not appear in the table because their valuations are not confirmed.
Competitive Comparison: This Week Against Other 2026 AI Financings
The week’s $1.5 billion top deal looks modest beside the largest financings we have tracked this year. We reported that OpenAI was eyeing up to $30 billion at a $1.25 trillion valuation, which is twenty times Tenstorrent’s round. We also covered the report that DeepSeek reportedly raised $15 billion ahead of an IPO. Those numbers define the top of the market, while this week’s list shows the layer just beneath it.
At the other end, smaller developer-tool deals continue. Supabase raised $150 million and bought Turso in the agent database race, a smaller round than any on this week’s confirmed list. Put side by side, the pattern is a barbell. A handful of mega-rounds sit at one end and focused infrastructure and application rounds in the $150 million to $325 million range fill the middle.
Within this week’s seven, the competitive logic differs by company. Tenstorrent competes on hardware economics. Flapping Airplanes competes on model efficiency. ASI and Xona compete for long-cycle institutional customers. Pathos AI and Warp Sciences compete against each other and against in-house pharma teams for AI-driven discovery contracts. Warhound competes with nothing recognizable, which is part of why the story traveled.
Historical Context: Series A Rounds Rarely Look Like This
A $1 billion Series A is not normal venture behavior. Series A rounds traditionally fund a first product and a small team, and most are a small fraction of that size. Flapping Airplanes’ round shows how far the AI lab model has stretched the stage, since training frontier-class models demands compute budgets that look more like infrastructure projects than software startups.
The other end of the stage ladder shows a different shift. Tenstorrent’s Series E, Pathos AI’s Series E and Xona’s Series D all come from companies that have raised several times already. Their rounds carry the later-stage logic of growth capital, where the money buys manufacturing, trials or deployment rather than a first prototype. The week’s list therefore spans the whole funding lifecycle, from a company less than 10 months past its seed to companies at Series D and Series E.
Expert View: What Investors and Founders Say
Public commentary on this week’s specific deals is thin, so we draw on two on-record statements from recent TechCrunch coverage of the AI funding market.
Asher Spector, founder of Flapping Airplanes, described the thesis behind his company’s raise in TechCrunch’s coverage of the round: “A model that’s a million times more data efficient is probably a million times easier to put into the economy.” The claim is a goal, not a measured result, but it explains why investors paid for a lab that has not yet shipped a product we can benchmark.
Earlier this month, TechCrunch reported that Ramp reached a $60 billion valuation on a $1.85 billion round. Christian Jensen, a partner at Dragoneer Investment Group, said of the company: “In just a few years, Ramp has become a much broader financial operations platform, with AI deeply embedded in how the company builds and operates. We believe Ramp is well on its way to becoming one of the defining companies of this era.”
The two comments point at the same buying logic from different directions. One backs a technical bet on efficiency. The other backs a company that already runs on AI inside a conventional business. Both fit the week’s mix of research labs, chip makers and AI-enabled operators.
Five Predictions for the Next Funding Cycle
These are our own forecasts based on the pattern in the seven confirmed rounds, not reported facts.
- Hardware keeps drawing nine-figure rounds. Tenstorrent’s $1.5 billion Series E shows investors will fund AI silicon challengers at scale. Expect more chip and systems companies to test the market.
- Efficiency labs follow Flapping Airplanes. A $1 billion Series A for a cheaper-models pitch invites copycats. Several new labs will likely market lower training and serving cost as their core claim.
- Pharma becomes a lead investor more often. Bristol-Myers Squibb leading Pathos AI sets a template. Other drugmakers have reasons to take stakes in AI discovery platforms.
- Dual-use and defense-adjacent startups keep raising. ASI, Xona and Warhound all sit near government or defense customers. That category should stay well funded through the next several weekly lists.
- Weekly totals stay lumpy. With two rounds supplying two-thirds of the confirmed money, any single week can swing on one or two deals. Treat weekly funding totals as noisy signals.
FAQ: This Week’s Biggest Funding Rounds
What was the biggest funding round this week? Tenstorrent’s $1.5 billion Series E, led by Trace Capital and Innovation X, at a $6.2 billion valuation, per Crunchbase News.
Who raised $1 billion in a Series A? Flapping Airplanes, a San Francisco AI lab building models meant to cost less to train and run. Lux Capital and Index Ventures led. The company had raised a $180 million seed round less than 10 months earlier.
How much did the seven confirmed rounds raise in total? $3.727 billion. That figure covers Tenstorrent, Flapping Airplanes, ASI, Xona, Pathos AI, Warp Sciences and Warhound, and it excludes the three entries we could not verify.
What does ASI do? The Boston company develops AI technology for securing and operating critical infrastructure in areas such as aviation, transportation and defense. It raised a $325 million Series C led by Spark Capital at a $3 billion valuation.
Which biotech companies raised money? Pathos AI raised $237 million in a Series E led by Bristol-Myers Squibb at a post-money valuation around $3 billion. Warp Sciences raised a $215 million Series A led by Lightspeed Venture Partners.
What is Warhound? A startup that wants to breed elite military dogs. Crunchbase News called its $200 million financing the quirkiest of the week.
Why are only seven of the ten rounds listed? The details of the other three are not confirmed in the sources we verified, and we do not publish names or figures we cannot support. The full list is in the original Crunchbase News roundup.
